Deng B Madut1,2, Matthew P Rubach1,2, John P Bonnewell1,2,3, Elena R Cutting4, Manuela Carugati1, Nathaniel Kalengo5, Michael J Maze6,7, Anne B Morrissey1, Blandina T Mmbaga5,8, Bingileki F Lwezaula9, Grace Kinabo5, Ronald Mbwasi5, Kajiru G Kilonzo5,8, Venance P Maro5,8, John A Crump1,2,7. 1. Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA. 2. Duke Global Health Institute, Duke University, Durham, North Carolina, USA. 3. Department of Pathology, Duke University, Durham, North Carolina, USA. 4. Duke University School of Medicine, Durham, North Carolina, USA. 5. Kilimanjaro Christian Medical Centre, Moshi, Tanzania. 6. Department of Medicine, University of Otago, Christchurch, New Zealand. 7. Centre for International Health, University of Otago, Dunedin, New Zealand. 8. Kilimanjaro Christian Medical University College, Tumaini University, Moshi, Tanzania. 9. Mawenzi Regional Referral Hospital, Moshi, Tanzania.
Abstract
OBJECTIVES: In 2010, WHO published guidelines emphasising parasitological confirmation of malaria before treatment. We present data on changes in fever case management in a low malaria transmission setting of northern Tanzania after 2010. METHODS: We compared diagnoses, treatments and outcomes from two hospital-based prospective cohort studies, Cohort 1 (2011-2014) and Cohort 2 (2016-2019), that enrolled febrile children and adults. All participants underwent quality-assured malaria blood smear-microscopy. Participants who were malaria smear-microscopy negative but received a diagnosis of malaria or received an antimalarial were categorised as malaria over-diagnosis and over-treatment, respectively. RESULTS: We analysed data from 2098 participants. The median (IQR) age was 27 (3-43) years and 1047 (50.0%) were female. Malaria was detected in 23 (2.3%) participants in Cohort 1 and 42 (3.8%) in Cohort 2 (p = 0.059). Malaria over-diagnosis occurred in 334 (35.0%) participants in Cohort 1 and 190 (17.7%) in Cohort 2 (p < 0.001). Malaria over-treatment occurred in 528 (55.1%) participants in Cohort 1 and 196 (18.3%) in Cohort 2 (p < 0.001). There were 30 (3.1%) deaths in Cohort 1 and 60 (5.4%) in Cohort 2 (p = 0.007). All deaths occurred among smear-negative participants. CONCLUSION: We observed a substantial decline in malaria over-diagnosis and over-treatment among febrile inpatients in northern Tanzania between two time periods after 2010. Despite changes, some smear-negative participants were still diagnosed and treated for malaria. Our results highlight the need for continued monitoring of fever case management across different malaria epidemiological settings in sub-Saharan Africa.
OBJECTIVES: In 2010, WHO published guidelines emphasising parasitological confirmation of malaria before treatment. We present data on changes in fever case management in a low malaria transmission setting of northern Tanzania after 2010. METHODS: We compared diagnoses, treatments and outcomes from two hospital-based prospective cohort studies, Cohort 1 (2011-2014) and Cohort 2 (2016-2019), that enrolled febrile children and adults. All participants underwent quality-assured malaria blood smear-microscopy. Participants who were malaria smear-microscopy negative but received a diagnosis of malaria or received an antimalarial were categorised as malaria over-diagnosis and over-treatment, respectively. RESULTS: We analysed data from 2098 participants. The median (IQR) age was 27 (3-43) years and 1047 (50.0%) were female. Malaria was detected in 23 (2.3%) participants in Cohort 1 and 42 (3.8%) in Cohort 2 (p = 0.059). Malaria over-diagnosis occurred in 334 (35.0%) participants in Cohort 1 and 190 (17.7%) in Cohort 2 (p < 0.001). Malaria over-treatment occurred in 528 (55.1%) participants in Cohort 1 and 196 (18.3%) in Cohort 2 (p < 0.001). There were 30 (3.1%) deaths in Cohort 1 and 60 (5.4%) in Cohort 2 (p = 0.007). All deaths occurred among smear-negative participants. CONCLUSION: We observed a substantial decline in malaria over-diagnosis and over-treatment among febrile inpatients in northern Tanzania between two time periods after 2010. Despite changes, some smear-negative participants were still diagnosed and treated for malaria. Our results highlight the need for continued monitoring of fever case management across different malaria epidemiological settings in sub-Saharan Africa.
Authors: Christian Nsanzabana; Ian M Hastings; Jutta Marfurt; Ivo Müller; Kay Baea; Lawrence Rare; Allan Schapira; Ingrid Felger; Bruno Betschart; Thomas A Smith; Hans-Peter Beck; Blaise Genton Journal: J Infect Dis Date: 2010-02-01 Impact factor: 5.226
Authors: S Bhatt; D J Weiss; E Cameron; D Bisanzio; B Mappin; U Dalrymple; K Battle; C L Moyes; A Henry; P A Eckhoff; E A Wenger; O Briët; M A Penny; T A Smith; A Bennett; J Yukich; T P Eisele; J T Griffin; C A Fergus; M Lynch; F Lindgren; J M Cohen; C L J Murray; D L Smith; S I Hay; R E Cibulskis; P W Gething Journal: Nature Date: 2015-09-16 Impact factor: 49.962
Authors: Shennae O'Boyle; Katia J Bruxvoort; Evelyn K Ansah; Helen E D Burchett; Clare I R Chandler; Siân E Clarke; Catherine Goodman; Wilfred Mbacham; Anthony K Mbonye; Obinna E Onwujekwe; Sarah G Staedke; Virginia L Wiseman; Christopher J M Whitty; Heidi Hopkins Journal: BMC Med Date: 2020-01-30 Impact factor: 8.775
Authors: Riley Hazard; Danstan Bagenda; Andrew J Patterson; Julia T Hoffman; Steven J Lisco; Olivier Urayeneza; Polyphile Ntihinyurwa; Christopher C Moore Journal: PLoS One Date: 2022-03-23 Impact factor: 3.240